cardiac assays

Webinar: Myocardial Injury in the Era of High-Sensitivity Troponins

Webinar Details:

Date: 9 September 2020
Time: 2.30 pm Malaysia/Singapore time
Location: Microsoft Teams Live

For a smoother webinar experience, please click on the link below to download the Microsoft Teams application to your computer or device that you will be using for this session.

Download Microsoft Teams



This webinar is organized in collaboration with the Malaysian Association of Clinical Biochemists (MACB) in an effort to advance online education for medical professionals even during these unprecedented times.

Register for this webinar by 7 September 2020!


  • Cardiac troponins are markers of myocardial necrosis and due to their high cardiac-specificity, are the preferred biomarker for the diagnosis of myocardial infarction.
  • The evolution from relatively insensitive cardiac troponin assays to high-sensitivity assays enables detections of lower levels of troponins and thus, has necessitated evolving testing approaches to optimize clinical utility.
  • The latest generation of high-sensitivity cardiac troponins support rapid diagnostic protocols aiding in the earlier discharge of a significant percentage of non-AMI patients, as well as aid a faster admission.
  • The sensitivity and precision offered by high-sensitivity assays is essential for rapid protocols in order to more accurately differentiate clinically significant change from assay imprecision.

Join us to review the latest updates in the guidelines related to high-sensitivity troponins and their clinical utility within Asia Pacific.


Clinical Marketing Manager, Laboratory Diagnostics, Siemens Healthineers

Webinar Recording

Register Here

Thank you to everyone who joined us for the webinar. If you have any questions, kindly direct them to us here.